Fast Moving Consumer GoodsAgricultural Food & other ProductsTea & Coffee

Bansisons Tea Industries Ltd

Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 27 filings·Updated 14 Oct 2026
Showing 10 of 27 filings.
14 Oct 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Dematerialisation requests processed; certificates mutilated and cancelled; securities listed; holdings reported for the quarter

Dematerialisation status

  • Securities received from depository participants for dematerialisation were processed.
  • Dematerialisation certificates were mutilated and cancelled after verification; depository names substituted as registered owner within 15 days.
  • Dematerialised securities have been listed on the stock exchanges.
  • NSDL: 491,505 shares; CDSL: 31,700 shares.
  • Physical shares: 5,806,795.
  • All dematerialisation requests were confirmed within 21 days of receipt.
Filed 16:31View Source
25 Sept 20261 filing
Insider Trading / SASTClosure of Trading Window

Novyra Pharmachem Limited – Trading Window Closure from Oct 1, 2026 until further notice, 48 hours after the declaration of its Unaudited Financial Results for the Quarter ended September 30, 2026

Novyra Pharmachem Limited – Trading Window Closure from Oct 1, 2026 until further notice, 48 hours after the declaration of its Unaudited Financial Results for the Quarter ended September 30, 2026

Filed 17:06View Source
22 Aug 20261 filing
Company UpdateGeneral

Name change approved to Novyra Pharmachem Limited; expansion into APIs, bulk drugs, and CDMO services

Name change and strategic focus

  • Name change approved to Novyra Pharmachem Limited; company expands into APIs, bulk drugs, CDMO services.
  • Certificate of Incorporation for name change issued by ROC on 19 January 2026.
  • New name to be updated with stock exchanges and depositories.
  • Business focus includes manufacturing, processing, and global trading of APIs, bulk drugs, intermediates.
Filed 14:03View Source
14 Aug 20261 filing
Board MeetingOutcome of Board Meeting

Novyra Pharmachem approves unaudited Q1 2026 standalone results and announces name change

Financial results approved

  • Board approved unaudited standalone Q1 30 June 2026 results.
  • Audit Committee reviewed results prior to Board approval.
  • Three reportable segments: Pharma, Real Estate, Tea Estate.
  • Results prepared under Ind AS 34 interim reporting.

Name change and corporate identity

  • Name changed to Novyra Pharmachem Limited from Bansisons Tea Industries Ltd.

Auditor reporting and regulatory notes

  • Independent Auditor's Review Report conducted; no material misstatement observed.
  • Results are unaudited and standalone; Ind AS 34 applied.

Board meeting details

  • Board meeting held on 14 August 2026.
Filed 18:07View Source
11 Aug 20261 filing
Board Meeting

Board to consider unaudited quarterly results for June 2026 and related business on Aug 14, 2026

Meeting Details

  • Board meeting on Friday, 14 August 2026, at the registered office of the company.

Key Agenda Items

  • Unaudited financial results for the quarter ended 30 June 2026, with Limited Review Report.
  • Any other business with the permission of the Chairman.
Filed 15:37View Source
13 Jul 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Dematerialisation processing completed; dematerialised securities listed on exchanges

Dematerialisation processing status

  • Securities received from depository participants for dematerialisation were processed.
  • Mutilated dematerialisation certificates were cancelled after verification and depository names substituted in the register within 15 days.
  • Securities dematerialised have been listed on the stock exchanges where the earlier issued securities are listed.
Filed 13:56View Source
18 Apr 20261 filing
Company UpdateBoard Meeting Rescheduled

Bansisons Tea Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2026 ,inter alia, to consider and approve Audited Financial ....

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 17:36View Source
21 Mar 20261 filing
Insider Trading / SASTClosure of Trading Window

Closure of Trading Window for the Quarter ended March 31, 2026

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 16:13View Source
20 Mar 20261 filing
Board MeetingOutcome of Board Meeting

Bansisons Tea Industries Ltd - 519353 - Board Meeting Outcome for Independent Directors Meeting

Independent Directors Meeting Outcome

  • Reviewed performance of non-independent directors and entire board
  • Assessed chairperson's performance with input from executive and non-executive directors
  • Evaluated quality, quantity, and timeliness of management-board information flow
Filed 18:50View Source
11 Mar 20261 filing
Board Meeting

Bansisons Tea Industries Ltd - 519353 - Board Meeting Intimation for Independent Directors Meeting

Meeting Details ️

  • Independent Directors meeting scheduled for 20th March 2026 at the company's registered office.

Key Agenda Items

  • Review performance of Non-Independent Directors and the Board as a whole.
  • Review the Chairperson's performance.
  • Assess quantity, quality, and timeliness of information flow.
Filed 17:03View Source
Showing 10 of 27 filings